Article Details
Retrieved on: 2024-08-07 21:20:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The firm currently has a buy rating on the biopharmaceutical company's stock. Get Theravance Biopharma alerts: Other equities research analysts also ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here